Ashwagandha: What Standardisation Actually Tells You
Ashwagandha has become the default answer to a stressful life, which is exactly the situation in which a supplement deserves the most scrutiny rather than the least. The research behind it is more substantial than most botanicals can claim. The way it is sold frequently outruns that research, and there are two or three things about it that genuinely matter and almost never appear on a label.
01What an adaptogen claim actually means
Ashwagandha is classified as an adaptogen, a term that gets used as though it were a mechanism. It isn't. It's a category description, originally proposed for plants said to help the body maintain balance under stress rather than pushing one system in a single direction.
That's a vague definition and it deserves to be treated as one. What gives ashwagandha more credibility than the word alone is that it has been studied in human trials for supporting normal stress resilience and sleep quality — a genuinely better evidence base than many botanicals sold alongside it. The trials are mostly small and heterogeneous, so the honest framing is a real but modest body of evidence rather than a settled one.
02The extract is the product
Here is the detail that decides everything, and it's the same lesson boswellia teaches.
The compounds of interest in ashwagandha are withanolides, and raw root powder contains them at low and variable levels. Nearly all the meaningful human research has used standardised extracts — material processed and verified to contain a specified percentage of withanolides — rather than ground root.
So a product listing "ashwagandha root powder 1,000 mg" and a product listing "ashwagandha extract standardised to 5% withanolides, 300 mg" are not two doses of the same thing. The second is closer to what the studies used, despite the smaller number on the front.
Named, standardised extracts exist precisely because this variability is the category's central problem. If a label doesn't state a withanolide percentage, it isn't telling you how potent the material is, and the milligram figure is close to meaningless on its own.
03Root versus whole plant
A second distinction rarely explained. Most research has used root extract. Some cheaper products use leaf material or a whole-plant blend, which is less expensive to produce and has a different constituent profile from what the trials tested.
A label specifying root extract is aligning itself with the research. One that just says "ashwagandha" is leaving the question open, and the cheaper answer is usually the reason.
04The part almost no label mentions
Ashwagandha interacts with thyroid hormone levels. Research has observed increases in thyroid hormones with supplementation, which is a genuine physiological effect rather than a theoretical concern.
For someone with normal thyroid function that is usually unremarkable. For someone managing a thyroid condition, or taking thyroid medication, it is exactly the kind of thing that should be discussed with a doctor before starting rather than discovered later. Given how many people take ashwagandha for fatigue — a symptom that overlaps heavily with thyroid issues — the population most drawn to it includes a lot of people for whom this matters.
It's also a plant in the nightshade family, which is worth knowing if you avoid those, and it's generally advised against in pregnancy. None of this makes ashwagandha unsafe. It makes it a supplement with real pharmacological activity, which is precisely why it works and precisely why it warrants a conversation rather than a casual purchase.
05Timing, and what to expect
Ashwagandha is not acute. The trials reporting effects generally run eight to twelve weeks of consistent daily use, so a fortnight's trial tells you nothing.
Timing is largely preference. Some take it in the evening for the sleep-related findings; others split it across the day. It's often taken with food, since it can be hard on an empty stomach for some people.
Worth saying plainly: ashwagandha is studied for supporting normal stress resilience in healthy people. It is not a treatment for anxiety or any diagnosed condition, and the distinction is not a legal formality — someone struggling meaningfully with their mental health deserves proper support rather than a capsule bought on the strength of a label.
06How to read the label
Does it specify root extract rather than leaf or unspecified plant material? Is a withanolide percentage stated, and is the extract standardised? Is the amount disclosed on its own line, or buried in a stress-support blend with five other botanicals and one combined weight? Does the dose bear a relationship to what has been studied, or is it a large number of unstandardised powder? And does the brand mention the thyroid interaction anywhere, because that omission tells you what it prioritises.
07How we approach it
Our approach is to state the extract type, the standardisation and the exact amount plainly, with no blend obscuring the number, and to publish an independent certificate of analysis for every lot on the product page.
Ashwagandha is one of the better-supported botanicals on the shelf, sold in a category where standardisation is the difference between a studied ingredient and expensive ground root. Check the percentage, check it's root, and if you take thyroid medication, ask your doctor first. That last sentence is the one the category should print and doesn't.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.



